Metastatic Myxofibrosarcoma with Durable Response to Temozolomide Followed by Atezolizumab: A Case Report.

Myxofibrosarcoma (MFS) is a well-recognized histotype of soft tissue sarcomas that generally presents with localized disease. Herein, we describe the case of a patient with metastatic MFS who experienced durable response to sixth-line therapy with temozolomide. Upon further progression, his tumor was notable for a high tumor mutational burden, and he was subsequently treated with seventh-line immunotherapy, atezolizumab, achieving a second durable response.

Surgical Site Infection, Readmission, and Reoperation After Posterior Long Segment Fusion.

Study Design: Retrospective case series.

Objective: We sought to identify risk factors associated with surgical site infection (SSI) after posterior long segment spinal fusion (PLSF).

Summary Of Background Data: Patients who undergo PLSF may be at elevated risk of SSI.